Literature DB >> 28215255

Performance characteristics of the French version of the severity hierarchy score for paediatric sleep apnoea screening in clinical settings.

Xuân-Lan Nguyên1, Pierre Lévy2, Nicole Beydon3, David Gozal4, Bernard Fleury5.   

Abstract

BACKGROUND: Paediatric obstructive sleep apnoea syndrome (OSAS) is a highly prevalent condition carrying increased risk for impaired cognitive and cardiovascular function. The standard diagnosis consists of full-night polysomnography (PSG), but limited access to PSG leads to substantial under-diagnosis. The use of a validated and simple diagnostic screening tool to predict OSAS could prioritise night sleep recordings in children at risk of OSAS, and help in clinical decision-making.
OBJECTIVE: This study aimed to prospectively assess the performance of the French version of the severity hierarchy score (SHS) in paediatric OSAS. This score consists of a discriminative subset of six respiratory items, and has already been validated in English for screening OSAS in the general paediatric population.
METHODS: A total of 96 children (mean age 7.1 ± 2.4 years; BMI z-score: -0.03 ± 1.50) were recruited; they had been were referred to two academic sleep centres in France for the putative diagnosis of sleep-disordered breathing. The parents completed the SHS questionnaire prior to PSG. Sensitivity and specificity of the SHS for detecting moderate OSAS, defined by an apnoea-hypopnoea index (AHI) of ≥5/hours of total sleep time (TST), were assessed, and ROC analysis was performed.
RESULTS: An SHS score of >2.75 exhibited an 82% sensitivity, 81% specificity, and 92% negative predictive value for detecting an AHI of ≥5/hour TST in the cohort.
CONCLUSION: The French version of the SHS emerged as favourably suited for the screening for OSAS in children.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnosis; Paediatric obstructive sleep apnoea syndrome; Polysomnography; Screening; Severity hierarchy score

Mesh:

Year:  2016        PMID: 28215255     DOI: 10.1016/j.sleep.2016.01.021

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  6 in total

1.  The Accuracy of an Ambulatory Level III Sleep Study Compared to a Level I Sleep Study for the Diagnosis of Sleep-Disordered Breathing in Children With Neuromuscular Disease.

Authors:  Haley Fishman; Colin Massicotte; Rhonda Li; Weeda Zabih; Laura C McAdam; Suhail Al-Saleh; Reshma Amin
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

2.  Prevalence of malocclusions and oral dysfunctions in children with persistent sleep-disordered breathing after adenotonsillectomy in the long term.

Authors:  Julia Cohen-Levy; Marie-Claude Quintal; Pierre Rompré; Fernanda Almeida; Nelly Huynh
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

3.  Feasibility of parent-attended ambulatory polysomnography in children with suspected obstructive sleep apnea.

Authors:  Iulia Ioan; Diane Weick; Cyril Schweitzer; Aurore Guyon; Laurianne Coutier; Patricia Franco
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

4.  Persistent sleep disordered breathing after adenoidectomy and/or tonsillectomy: a long-term survey in a tertiary pediatric hospital.

Authors:  Julia Cohen-Levy; Marie-Claude Quintal; Anthony Abela; Pierre Rompré; Fernanda R Almeida; Nelly Huynh
Journal:  Sleep Breath       Date:  2018-10-15       Impact factor: 2.816

5.  Management of obstructive sleep apnea in children: a Canada-wide survey.

Authors:  J Cousineau; A-S Prévost; M-C Battista; M Gervais
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-08-31

6.  Accuracy of the sleep clinical record for the diagnosis of pediatric moderate-to-severe obstructive sleep apnea syndrome.

Authors:  Anna Maria Mylona; Georgia Rapti; George Vavougios; Vasileios A Lachanas; Panagiotis Liakos; Charalambos Skoulakis; Athanasios G Kaditis; Konstantinos Gourgoulianis; Emmanouil I Alexopoulos
Journal:  Sleep Breath       Date:  2021-08-08       Impact factor: 2.816

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.